Patent US4697224A successfully refreshed from Google Patents.
Patent US2406315A successfully refreshed from Google Patents.
Patent US3702578A successfully refreshed from Google Patents.
Patent US4324679A successfully refreshed from Google Patents.
Patent US1934957A successfully refreshed from Google Patents.
US4844907A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutical composition comprising analgesic and anti-inflammatory agent
Assignee: Euro Celtique SA
•
Filing: 1986-08-14
•
Granted: 1989-07-04
•
Expires: 2006-08-14
Abstract
Abstract A pharmaceutical composition in the form of a multiphase (especially a bilayered, optionally coated) tablet. The tablet has a narcotic analgesic phase containing a therapeutically effective quantity of a narcotic analgesic or an analgesically effective salt thereof (e.g. codeine phosphate) and a non-steroidal anti-inflammatory phase containing a therapeutically effective quantity of a non-steroidal anti-inflammatory carboxylic acid or an anti-inflammatory salt or ester thereof (e.g. ibuprofen). The narcotic analgesic phase is free from a non-steroidal anti-inflammatory carboxylic acid or salt or ester thereof, stearic acid and stearate salt, and the non-steroidal anti-inflammatory phase is free from a narcotic analgesic or salt thereof, stearic acid and a stearate salt. Further, both the narcotic analgesic phase and the non-steroidal anti-inflammatory phase contain a self-lubricating, compression aid, especially a self-lubricating, direct compression aid, such as microcrystalline cellulose.
Inventors
- 👤 Gordon A. Elger
- 👤 Stewart T. Leslie
- 👤 Sandra T. A. Malkowska
- 👤 Ronald B. Miller
- 👤 Philip J. Neale
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 09:09
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/33; A61K31/395; A61K31/435; A61K31/47; A61K31/485; A61K9/00; A61K9/20; A61K9/2072; A61K9/2086; A61K9/209; A61P; A61P25/00; A61P25/04
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
133 words
A pharmaceutical composition in the form of a multiphase tablet comprising at least one narcotic analgesic phase containing a therapeutically effective quantity of a narcotic analgesic or an analgesically effective salt thereof and at least one non-steroidal anti-inflammatory phase containing a therapeutically effective quantity of a non-steroidal anti-inflammatory carboxylic acid or an anti-inflammatory salt or ester thereof wherein the at least one narcotic analgesic phase is free from a non-steroidal anti-inflammatory carboxylic acid or salt or ester thereof, stearic acid and a stearate salt, and the at least one non-steroidal anti-inflammatory phase is free from a narcotic analgesic or salt thereof, stearic acid and a stearate salt, and further wherein both the at least one narcotic analgesic phase and the at least one non-steroidal anti-inflammatory phase contain at least one self-lubricating, compression aid.
Claim 2
Dependent Claim
133 words
A pharmaceutical composition in the form of a multiphase tablet comprising at least one narcotic analgesic phase containing a therapeutically effective quantity of a narcotic analgesic or an analgesically effective salt thereof and at least one non-steroidal anti-inflammatory phase containing a therapeutically effective quantity of a non-steroidal anti-inflammatory carboxylic acid or an anti-inflammatory salt or ester thereof wherein the at least one narcotic analgesic phase is free from a non-steroidal anti-inflammatory carboxylic acid or salt or ester thereof, stearic acid and a stearate salt, and the at least one non-steroidal anti-inflammatory phase is free from a narcotic analgesic or salt thereof, stearic acid and a stearate salt, and further wherein both the at least one narcotic analgesic phase and the at least one non-steroidal anti-inflammatory phase contain at least one self-lubricating, compression aid.
Claim 3
Dependent Claim
26 words
A composition according to claim 1 wherein the narcotic analgesic comprises a morphinan-6-ol or a morphinan-6-one derivative, selected from morphine, ethylmorphine, hydromorphone, hydrocodone, dihydrocodeine and codeine.
Claim 4
Dependent Claim
18 words
A composition according to claim 1 wherein the analgesically effective salt of the narcotic analgesic comprises codeine phosphate.
Claim 5
Dependent Claim
39 words
A composition according to claim 1 wherein the non-steroidal anti-inflammatory carboxylic acid comprises at least one of naproxen, a benzeneacetic acid, selected from alclofenac, diclofenac and fenclofenac, and a 2-phenylpropionic acid, selected from fenoprofen, flurbiprofen, indoprofen, ketoprofen and ibuprofen.
Claim 6
Dependent Claim
14 words
A composition according to claim 4 wherein the non-steroidal anti-inflammatory carboxylic acid comprises ibuprofen.
Claim 7
Dependent Claim
35 words
A composition according to claim 1 wherein the at least one self lubricating, compression aid comprises at least one self lubricating, direct compression aid, selected from microcrystalline cellulose and a free flowing, directly compressible starch.
Claim 8
Dependent Claim
28 words
A composition according to claim 1 wherein the concentration of the compression aid in the at least one non-steroidal anti-inflammatory phase is between 10% and 90% (by wt).
Claim 9
Dependent Claim
16 words
A composition according to claim 7 wherein the concentration is between 15% and 40% (by wt).
Claim 10
Dependent Claim
28 words
A composition according to claim 1 wherein the concentration of the compression aid in the at least one narcotic analgesic phase is between 50% and 99% (by wt).
Claim 11
Dependent Claim
16 words
A composition according to claim 9 wherein the concentration is between 70% and 95% (by wt).
Claim 12
Dependent Claim
13 words
A composition according to claim 1 in the form of a layered tablet.
Claim 13
Dependent Claim
13 words
A composition according to claim 11 in the form of a bilayered tablet.
Claim 14
Dependent Claim
83 words
A wet granulation process for the preparation of a pharmaceutical composition according to claim 1 comprising (a) granulating a narcotic analgesic or an analgesically effective salt thereof with at least one self-lubricating, compression aid to form narcotic analgesic granules, (b) granulating a non-steroidal anti-inflammatory carboxylic acid or an anti-inflammatory salt or ester thereof with at least one self lubricating, compression aid to form non-steroidal anti-inflammatory granules, and (c) compressing the narcotic analgesic granules and the non-steroidal anti-inflammatory granules to form a multiphase tablet.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-07-03 | 1993-01-02 | 1993-07-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-07-03 | 1997-01-02 | 1997-07-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-07-03 | 2001-01-02 | 2001-07-04 | $7700.00 | Window Closed / Lapsed |